What actions has the Food and Drug Administration taken to further the Trump administration’s goal to bring down prescription drug prices? In a new post, former congressman Henry Waxman and other experts at Waxman Strategies present a detailed timeline of the FDA’s strategy on prices and highlight some of its key moves to inject competition into the growing market for biologic drugs.